Bel Fuse (NASDAQ:BELFA) Sets New 1-Year High - Time to Buy?

Key Points

• Bel Fuse Inc. (NASDAQ:BELFA) shares reached a new 52-week high of $127.60 during trading, with a recent price at $125.25, marking a significant rise from its previous close of $119.15.
• Analysts have a consensus rating of "Buy" for Bel Fuse, with one analyst rating it a Strong Buy and an average target price set at $115.00.
• The company recently declared a quarterly dividend of $0.06, which will be paid on October 31, 2023, reflecting a modest annualized dividend yield of 0.2% and a payout ratio of 6.22%.

Bel Fuse Inc. (NASDAQ:BELFA - Get Free Report) shares hit a new 52-week high during trading on Friday . The stock traded as high as $127.60 and last traded at $125.25, with a volume of 19492 shares changing hands. The stock had previously closed at $119.15.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a "hold (c)" rating on shares of Bel Fuse in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $115.00.

Bel Fuse Price Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 3.05 and a quick ratio of 1.72. The stock has a 50 day moving average price of $116.89 and a 200-day moving average price of $91.57. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of 32.45 and a beta of 1.25.

Bel Fuse (NASDAQ:BELFA - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The scientific and technical instruments company reported $1.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.43. The firm had revenue of $168.30 million for the quarter, compared to analyst estimates of $149.60 million. Bel Fuse had a return on equity of 18.33% and a net margin of 8.59%. Bel Fuse has set its Q3 2025 guidance at EPS.

Bel Fuse Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Wednesday, October 15th will be paid a $0.06 dividend. The ex-dividend date of this dividend is Wednesday, October 15th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.2%. Bel Fuse's payout ratio is currently 6.22%.

Institutional Trading of Bel Fuse

A number of institutional investors have recently made changes to their positions in BELFA. FNY Investment Advisers LLC purchased a new position in Bel Fuse during the second quarter worth approximately $51,000. Tower Research Capital LLC TRC lifted its position in Bel Fuse by 447.1% during the second quarter. Tower Research Capital LLC TRC now owns 744 shares of the scientific and technical instruments company's stock worth $67,000 after buying an additional 608 shares in the last quarter. Rhumbline Advisers lifted its position in Bel Fuse by 41.5% during the first quarter. Rhumbline Advisers now owns 2,613 shares of the scientific and technical instruments company's stock worth $188,000 after buying an additional 767 shares in the last quarter. Makaira Partners LLC purchased a new position in Bel Fuse during the first quarter worth approximately $288,000. Finally, Cynosure Group LLC purchased a new position in Bel Fuse during the first quarter worth approximately $310,000. 6.01% of the stock is owned by institutional investors and hedge funds.

About Bel Fuse

Bel Fuse Inc designs, manufactures, markets, and sells products that power, protect, and connect electronic circuits. The company's products are used in the networking, telecommunications, computing, general industrial, high-speed data transmission, military, commercial aerospace, transportation, and e-Mobility industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.